Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in-stent restenosis

Experimental and Therapeutic Medicine

Volumn 5, Issue 2, 2013, Pages 539-544

  Guo, Su Xia ^a   Yang, Zhen Yu ^a   Wang, Ru Xing ^a   Yang, Ying ^a   Cao, Hua Ming ^a   Zhang, Tao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Connexin37; Coronary heart disease; Gene polymorphism; In stent restenosis

Indexed keywords

CONNEXIN 37; DNA;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE;

EID: 84871354387     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.852     Document Type: Article

References (27)

1. Serruys PW, Kutryk MJ and Ong AT: Coronary-artery stents. N Engl J Med 354: 483-495, 2006.
2. Cheng G, Wang H, Chen M, et al: Lack of evidence to support the association of polymorphisms within the TNFSF4 gene and coronary heart disease in a Chinese Han population. Exp Ther Med 2: 275-280, 2011.
3. Yan KP, Guo Y, Xing Z, et al: Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats. Exp Ther Med 3: 314-318, 2012.
4. Marfella R, Sasso FC, Siniscalchi M, et al: Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction. J Clin Endocrinol Metab 97: 2862-2871, 2012.
5. Kastrati A, Schömig A, Elezi S, et al: Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation 97: 2396-2401, 1998.
6. Weintraub WS, Kosinski AS, Brown CL III, et al: Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 21: 6-14, 1993.
7. Saez JC, Berthoud VM, Branes MC, et al: Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83: 1359-1400, 2003.
8. Fang JS, Angelov SN, Simon AM and Burt JM: Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. Am J Physiol Heart Circ Physiol 301: H1872-H1881, 2011.
9. Kanady JD, Dellinger MT, Munger SJ, Witte MH and SimonAM: Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 354: 253-266, 2011.
10. Morel S and Kwak BR: Roles of connexins in atherosclerosis and ischemia-reperfusion injury. Curr Pharm Biotechnol 13: 17-26, 2012.
11. Yeh HI, Chang HM, Lu WW, et al: Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 48: 1377-1389, 2000.
12. Pfenniger A, Wong C, Sutter E, et al: Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells. J Mol Cell Cardiol 53: 299-309, 2012.
13. Fang JS, Angelov SN, Simon AM and Burt JM: Cx40 is required for, and cx37 limits, postischemic hindlimb perfusion, survival and recovery. J Vasc Res 49: 2-12, 2012.
14. Boerma M, Forsberg L, Van Zeij L, et al: A genetic polymorphismin connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 246: 211-218, 1999.
15. Yeh HL, Chou Y, Liu HF, et al: Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 81: 251-255, 2001.
16. Han YL, Xi SY, Zhang XL, et al: Association of C1019T polymorphism in the Connexin 37 gene and coronary artery disease in Chinese Han population. Zhonghua Yi Xue Za Zhi 87:100-104, 2007 (In Chinese).
17. Wong CW, Christen T, Pfenniger A, et al: Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclorosis 191: 355-361, 2007.
18. Yamada Y, Izawa H, Ichiwara S, et al: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347: 1916-1923, 2002.
19. Listi F, Candore G, Lio D, et al: Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 102: 269-271, 2005.
20. Chan JM, Rhee JW, Drum CL, et al: In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci U S A 108: 19347-19352, 2011.
21. +cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics. Thromb Haemost101: 1138-1146, 2009.
22. Stiefel P, Moreno-Luna R, Vallejo-Vaz AJ, et al: Which parameter is better to define endothelial dysfunction in a test of postocclusive hyperemia measured by laser-Doppler flowmetry? Coron Artery Dis 23: 57-61, 2012.
23. Leu HB, Chung CM, Chuang SY, et al: Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke. Atherosclerosis 214: 101-106, 2011.
24. Puljung MC, Berthoud VM, Beyer EC and Hanck DA: Polyvalent cations constitute the voltage gating particle in human connexin37 hemichannels. J Gen Physiol 124: 587-603, 2004.
25. Cai WJ, Koltai S, Kocsis E, et al: Connexin37, not Cx40 and Cx43, is induced in vascular smooth muscle cells during coronary arteriogenesis. J Mol Cell Cardiol 33: 957-967, 2001.
26. Wong CW, Christen T, Roth I, et al: Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 12: 950-954, 2006.
27. Collings A, Raitakari OT, Juonala M, et al: The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism-The Cardiovascular Risk in Young Finns Study. Clin Chem Lab Med46: 1102-1108, 2008.